Table of Contents

Pharmaceuticals, Volume 4, Issue 3 (March 2011), Pages 429-566

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-8
p. 429-456
Pharmaceuticals 2011, 4(3), 429-456; doi:10.3390/ph4030429
Received: 9 February 2011; in revised form: 18 February 2011 / Accepted: 21 February 2011 / Published: 25 February 2011
Show/Hide Abstract | Cited by 7 | PDF Full-text (644 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Genes, Mechanisms and Drugs for Asthma)
p. 457-469
Pharmaceuticals 2011, 4(3), 457-469; doi:10.3390/ph4030457
Received: 13 December 2010; in revised form: 17 February 2011 / Accepted: 18 February 2011 / Published: 25 February 2011
Show/Hide Abstract | Cited by 3 | PDF Full-text (1028 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue GPCR Based Drug Discovery)
p. 470-484
Pharmaceuticals 2011, 4(3), 470-484; doi:10.3390/ph4030470
Received: 25 January 2011; in revised form: 23 February 2011 / Accepted: 28 February 2011 / Published: 4 March 2011
Show/Hide Abstract | Cited by 1 | PDF Full-text (209 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Opioids)
p. 485-493
Pharmaceuticals 2011, 4(3), 485-493; doi:10.3390/ph4030485
Received: 3 February 2011; in revised form: 4 March 2011 / Accepted: 7 March 2011 / Published: 9 March 2011
Show/Hide Abstract | Cited by 1 | PDF Full-text (236 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue GPCR Based Drug Discovery)
p. 494-508
Pharmaceuticals 2011, 4(3), 494-508; doi:10.3390/ph4030494
Received: 28 December 2010; in revised form: 17 January 2011 / Accepted: 11 February 2011 / Published: 10 March 2011
Show/Hide Abstract | Cited by 5 | PDF Full-text (550 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Aptamer-Based Therapeutics)
p. 509-523
Pharmaceuticals 2011, 4(3), 509-523; doi:10.3390/ph4030509
Received: 3 February 2011; in revised form: 9 March 2011 / Accepted: 9 March 2011 / Published: 14 March 2011
Show/Hide Abstract | Cited by 1 | PDF Full-text (690 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue GPCR Based Drug Discovery)
abstract graphic
p. 524-550
Pharmaceuticals 2011, 4(3), 524-550; doi:10.3390/ph4030524
Received: 17 December 2010; in revised form: 7 March 2011 / Accepted: 7 March 2011 / Published: 14 March 2011
Show/Hide Abstract | PDF Full-text (707 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue GPCR Based Drug Discovery)
p. 551-566
Pharmaceuticals 2011, 4(3), 551-566; doi:10.3390/ph4030551
Received: 8 February 2011; in revised form: 23 February 2011 / Accepted: 10 March 2011 / Published: 17 March 2011
Show/Hide Abstract | Cited by 1 | PDF Full-text (501 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Betablockers)
Select/unselect all
Displaying article 1-8
Select articles Export citation of selected articles as:
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert